Literature DB >> 18924264

Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice.

W Chen1, Y -M Li, M -H Yu.   

Abstract

BACKGROUND: Type 1 diabetes mellitus (DM) is a chronic autoimmune disease that is related to the disequilibrium state of Th1 and Th2 subgroups of helper T lymphocyte (Th) and their cytokines. Astragalus polysaccharides (APS) are bioactive components extracted from one of the traditional Chinese herbs, used to enhance the function of human immune system.
OBJECTIVE: To investigate the effects of APS on preventing type 1 DM and Th1/Th2-subtype cytokines, we compared the results of administration of APS and normal saline (NS) on non-obese diabetic (NOD) mice. SUBJECTS AND METHODS: APS or NS was administered to 4-week-old mice at a dose of 2.0 g/kg per day for 10 weeks. At 40 weeks, blood glucose, serum C-peptide (C-P) and GAD antibody were measured; pancreas was examined histologically; the intra-islet lymphocyte infiltration and T lymphocyte subsets in the spleen were analysed; the gene expression of IL-1 beta, IL-2, IL-6, IL-12, TNF-alpha, INF-gamma, IL-4, IL-5, IL-10, TGF-beta, Bcl-2, SOD, Fas and iNOS were measured by RT-PCR.
RESULTS: The results showed that APS-administered NOD mice had a lower incidence rate of type 1 DM, lower serum C-P level, better histologic findings of pancreatic islets, and a lower D4+/CD8+ ratio of T lymphocytes from the spleen and the infiltrated islets. RT-PCR analysis showed gene expression levels are lower in IL-1 beta, IL-2, IL-6, IL-12, TNF-alpha, INF-gamma, Fas, iNOS, and higher in IL-4, IL-5, IL-10, TGF-beta, Bcl-2, SOD in the pancreatic tissue from APS-administered NOD mice as compared to the NS group.
CONCLUSIONS: These results demonstrated the effects of Astragalus polysaccharides on the prevention of type 1 DM in NOD mice by correcting the imbalance between the Th1/Th2 cytokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18924264     DOI: 10.1055/s-2008-1058081

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  16 in total

1.  Improvement of myocardial glycolipid metabolic disorder in diabetic hamster with Astragalus polysaccharides treatment.

Authors:  Wei Chen; Yan-Ping Xia; Wen-Jie Chen; Mao-Hua Yu; Yi-Ming Li; Hong-Ying Ye
Journal:  Mol Biol Rep       Date:  2012-03-17       Impact factor: 2.316

2.  Administration of a decoction of sucrose- and polysaccharide-rich radix astragali (huang qi) ameliorated insulin resistance and Fatty liver but affected Beta-cell function in type 2 diabetic rats.

Authors:  Yi-Chen Juan; Yao-Haur Kuo; Chia-Chuan Chang; Li-Jie Zhang; Yan-Yu Lin; Chia-Yun Hsu; Hui-Kang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-10       Impact factor: 2.629

3.  Pharmacokinetics and hepatic uptake of gliquidone affected by Huangqi injection.

Authors:  Fan Zhang; Yuhui Wei; Yan Zhou; Dan Wang; Liting Zhou; Jianping Zhang; Xinan Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-10-02       Impact factor: 2.441

4.  Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review.

Authors:  Zeinab Nazarian-Samani; Robert D E Sewell; Zahra Lorigooini; Mahmoud Rafieian-Kopaei
Journal:  Curr Diab Rep       Date:  2018-08-13       Impact factor: 4.810

5.  Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice.

Authors:  Wei Chen; Wenjie Chen; Yanping Xia; Xuelan Zhao; Hao Wang; Maohua Yu; Yiming Li; Hongying Ye; Yu Zhang
Journal:  Mol Biol Rep       Date:  2012-11-30       Impact factor: 2.316

6.  Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals.

Authors:  Karen L Denzler; Robert Waters; Bertram L Jacobs; Yvan Rochon; Jeffrey O Langland
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

7.  Qizhi Jiangtang Jiaonang Improves Insulin Signaling and Reduces Inflammatory Cytokine Secretion and Reactive Oxygen Species Formation in Insulin Resistant HepG2 Cells.

Authors:  Xiao-Tian Zhang; Chun-Jiang Yu; Jian-Wei Liu; Yan-Ping Zhang; Chao Zhang; Chen-Xue Song; Jing-Shu Xie; Jing-Ying Sai; Jing-Tong Zheng; Fang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-05       Impact factor: 2.629

8.  Extracts of Rhizoma polygonati odorati prevent high-fat diet-induced metabolic disorders in C57BL/6 mice.

Authors:  Ming Gu; Yu Zhang; Shengjie Fan; Xiaobo Ding; Guang Ji; Cheng Huang
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

9.  The critical role of Astragalus polysaccharides for the improvement of PPARα [ correction of PPRAα]-mediated lipotoxicity in diabetic cardiomyopathy.

Authors:  Wei Chen; Yanping Xia; Xuelan Zhao; Hao Wang; Wenjie Chen; Maohua Yu; Yiming Li; Hongying Ye; Yu Zhang
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

Review 10.  Recent Advances in Astragalus membranaceus Anti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents.

Authors:  Kojo Agyemang; Lifeng Han; Erwei Liu; Yi Zhang; Tao Wang; Xiumei Gao
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.